Commercialization of a protein product from transgenic maize

Abstract

Bovine trypsin can be synthesized in transgenic maize, nut lack of public acceptance is the major barrier to producing pharmaceutical or industrial products in plants. Response to this public distrust has driven current regulations to be quite restrictive. The scientific community and the regulatory agencies are striving to gather substantive safety data to support regulations that are based on scientific principles and will protect the public as well as allow this new industry to develop.